You can always press Enter⏎ to continue
Weight Loss Program Enrollment Questionnaire

Weight Loss Program Enrollment Questionnaire

HIPAA

Compliance

  • 1

    This questionnaire is for patients who are NEW to MinuteMD and it will ask you various health-related questions in order to provide you with a number of different weight loss prescription options that are available to you based on your responses. We strive to offer all GLP-1 weight loss options, but please keep in mind that not all options may be available to you based on your responses to the questions. If you are not eligible for treatment with GLP-1 medications, you will be presented with some alternative options.

    It is extremely important that you answer the questions honestly by the patient who will be receiving the medication once prescribed.

    It is expected that it will take most people approximately 10 minutes to complete this questionnaire and it will require you to provide a picture of a current, non-expired US-government issued photo identification to match the name of the patient.

    Once you complete the questionnaire, you will be presented with treatment options which you pre-qualify for based on your responses to the following questionnaire.

    Press
    Enter
  • 2
    Press
    Enter
  • 3
    This must match the patient's date of birth on photo identification.
    -
    Pick a Date
    Press
    Enter
  • 4
    Please enter it twice to confirm accuracy. This is extremely important to be able to receive all notifications.This MUST be the patient's email address due to HIPAA patient privacy laws.
    Press
    Enter
  • 5
    Press
    Enter
  • 6
    Press
    Enter
  • 7
    This is the address where the pharmacy will ship the order once approved.Medication can only be shipped to the patient's name directly and not to a third party.
    • Please Select
    • Alabama
    • Alaska
    • Arizona
    • Arkansas
    • California
    • Colorado
    • Connecticut
    • Delaware
    • District of Columbia
    • Florida
    • Georgia
    • Hawaii
    • Idaho
    • Illinois
    • Indiana
    • Iowa
    • Kansas
    • Kentucky
    • Louisiana
    • Maine
    • Maryland
    • Massachusetts
    • Michigan
    • Minnesota
    • Mississippi
    • Missouri
    • Montana
    • Nebraska
    • Nevada
    • New Hampshire
    • New Jersey
    • New Mexico
    • New York
    • North Carolina
    • North Dakota
    • Ohio
    • Oklahoma
    • Oregon
    • Pennsylvania
    • Rhode Island
    • South Carolina
    • South Dakota
    • Tennessee
    • Texas
    • Utah
    • Vermont
    • Virginia
    • Washington
    • West Virginia
    • Wisconsin
    • Wyoming
    Please Select
    • Please Select
    • Afghanistan
    • Albania
    • Algeria
    • American Samoa
    • Andorra
    • Angola
    • Anguilla
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Aruba
    • Australia
    • Austria
    • Azerbaijan
    • The Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belgium
    • Belize
    • Benin
    • Bermuda
    • Bhutan
    • Bolivia
    • Bosnia and Herzegovina
    • Botswana
    • Brazil
    • Brunei
    • Bulgaria
    • Burkina Faso
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Cayman Islands
    • Central African Republic
    • Chad
    • Chile
    • China
    • Christmas Island
    • Cocos (Keeling) Islands
    • Colombia
    • Comoros
    • Congo
    • Cook Islands
    • Costa Rica
    • Cote d'Ivoire
    • Croatia
    • Cuba
    • Curaçao
    • Cyprus
    • Czech Republic
    • Democratic Republic of the Congo
    • Denmark
    • Djibouti
    • Dominica
    • Dominican Republic
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Ethiopia
    • Falkland Islands
    • Faroe Islands
    • Fiji
    • Finland
    • France
    • French Polynesia
    • Gabon
    • The Gambia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar
    • Greece
    • Greenland
    • Grenada
    • Guadeloupe
    • Guam
    • Guatemala
    • Guernsey
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Honduras
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran
    • Iraq
    • Ireland
    • Israel
    • Italy
    • Jamaica
    • Japan
    • Jersey
    • Jordan
    • Kazakhstan
    • Kenya
    • Kiribati
    • North Korea
    • South Korea
    • Kosovo
    • Kuwait
    • Kyrgyzstan
    • Laos
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macau
    • Macedonia
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Martinique
    • Mauritania
    • Mauritius
    • Mayotte
    • Mexico
    • Micronesia
    • Moldova
    • Monaco
    • Mongolia
    • Montenegro
    • Montserrat
    • Morocco
    • Mozambique
    • Myanmar
    • Nagorno-Karabakh
    • Namibia
    • Nauru
    • Nepal
    • Netherlands
    • Netherlands Antilles
    • New Caledonia
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue
    • Norfolk Island
    • Turkish Republic of Northern Cyprus
    • Northern Mariana
    • Norway
    • Oman
    • Pakistan
    • Palau
    • Palestine
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn Islands
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Republic of the Congo
    • Romania
    • Russia
    • Rwanda
    • Saint Barthelemy
    • Saint Helena
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Martin
    • Saint Pierre and Miquelon
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Sao Tome and Principe
    • Saudi Arabia
    • Senegal
    • Serbia
    • Seychelles
    • Sierra Leone
    • Singapore
    • Slovakia
    • Slovenia
    • Solomon Islands
    • Somalia
    • Somaliland
    • South Africa
    • South Ossetia
    • South Sudan
    • Spain
    • Sri Lanka
    • Sudan
    • Suriname
    • Svalbard
    • eSwatini
    • Sweden
    • Switzerland
    • Syria
    • Taiwan
    • Tajikistan
    • Tanzania
    • Thailand
    • Timor-Leste
    • Togo
    • Tokelau
    • Tonga
    • Transnistria Pridnestrovie
    • Trinidad and Tobago
    • Tristan da Cunha
    • Tunisia
    • Turkey
    • Turkmenistan
    • Turks and Caicos Islands
    • Tuvalu
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • United States
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Vatican City
    • Venezuela
    • Vietnam
    • British Virgin Islands
    • Isle of Man
    • US Virgin Islands
    • Wallis and Futuna
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe
    • Other
    Press
    Enter
  • 8
    Failure to provide this now may delay your order and our customer service team will reach out to you to provide this within 24 business hours. Our providers require unexpired government issued photo ID to treat patients (Drivers License/Passport).
    Press
    Enter
  • 9
    These medications include semaglutide (Ozempic®, Wegovy®, Rybelsus), tirzepatide (Mounjaro®, Zepbound®) or liraglutide.
    Please Select
    • Please Select
    • Yes, I currently am taking one of these medications and have taken my last dose within the last 2 months.
    • No, I do not currently take any GLP-1 medication.
    Press
    Enter
  • 10
    Please Select
    • Please Select
    • Semaglutide/Ozempic/Wegovy
    • Tirzepatide/Mounjaro/Zepbound
    • Liraglutide
    Press
    Enter
  • 11
    Not Applicable
    • Please Select
    • 0.25mg/week
    • 0.50mg/week
    • 1.0mg/week
    • 1.7mg/week
    • 2.5mg/week
    Press
    Enter
  • 12
    Not Applicable
    • Please Select
    • 2.5mg/week
    • 5mg/week
    • 7.5mg/week
    • 10mg/week
    • 12.5mg/week
    • 15mg/week
    Press
    Enter
  • 13
    Select all that apply, or select No if you have not experienced any side effects from your current medication.
    Press
    Enter
  • 14
    Press
    Enter
  • 15
    Press
    Enter
  • 16
    Press
    Enter
  • 17
    Press
    Enter
  • 18
    Press
    Enter
  • 19
    Press
    Enter
  • 20
    Press
    Enter
  • 21
    Press
    Enter
  • 22
    If you do not agree, please close this questionnaire and do not continue.
    Press
    Enter
  • 23
    Press
    Enter
  • 24
    Press
    Enter
  • 25
    Press
    Enter
  • 26
    If you do not agree, please close this questionnaire and do not continue.
    Press
    Enter
  • 27
    Please Select
    • Please Select
    • Within the last year
    • 1-5 years ago
    • More than 5 years ago
    • Unsure
    Press
    Enter
  • 28
    Please Select
    • Please Select
    • Actively managing
    • Some efforts
    • No active efforts
    Press
    Enter
  • 29
    Please Select
    • Please Select
    • Sedentary (I don't exercise)
    • Light
    • Moderate
    • Vigorous
    Press
    Enter
  • 30
    Please Select
    • Please Select
    • None
    • Minor modifications
    • Significant dietary changes
    Press
    Enter
  • 31
    Choose "NONE OF THE ABOVE" if none of these choices are applicable.
    Press
    Enter
  • 32
    Press
    Enter
  • 33
    You indicated one or more current or previous medication conditions above. Please tell us more information about each condition that you indicated was applicable to you.
    Press
    Enter
  • 34
    Press
    Enter
  • 35
    Check all that apply, or if you have no allergies to these medications, check "None of the Above".
    Press
    Enter
  • 36
    Check all that apply, or if you do not take any of these medications, check "None of the Above".
    Press
    Enter
  • 37
    Press
    Enter
  • 38
    Press
    Enter
  • 39
    Press
    Enter
  • 40
    Press
    Enter
  • 41
    Our providers have not yet reviewed your intake form, but you may be a candidate for a brand name product which we are happy to provide. Based on our experience as providers, we have developed an alternative dosing protocol which may provide a more comfortable experience for you. How would you like to proceed?
    Press
    Enter
  • 42
    Press
    Enter
  • 43
    By my signature below, I verify that I am the patient and that I have answered the questions asked in this intake form. I confirm that I have reviewed and understood all the questions asked of me. I attest that the answers and information I have provided in this questionnaire are true and complete to the best of my knowledge. I understand that it is critical to my health to share complete health information with my doctor. I will not hold the doctor or affiliated medical practice responsible for any oversights or omissions, whether intentional or not, in the information that I provided.
    Clear
    Press
    Enter
  • 44
    If you do not agree with the statement below, please close this questionnaire and do not continue.
    Press
    Enter
  • 45
    Based on your answers provided, you are conditionally pre-qualified for treatment with one of the following programs.
    Press
    Enter
  • 46
    Based on your answers provided, you are conditionally pre-qualified for treatment with one of the following programs. If you do not see your expected product(s) here, one or more of your previous answers may prevent it from being available.
    Press
    Enter
  • 47
    I verify that I am the patient and that I have answered the questions asked in this intake form. I attest that the answers and information I have provided in this questionnaire is true and complete to the best of my knowledge. I understand that it is critical to my health to share complete health information with my doctor. I will not hold the doctor or affiliated medical practice responsible for any oversights or omissions, whether intentional or not, in the information provided.
    Press
    Enter
  • 48
    You are requesting treatment with a GLP-1 (Ozempic, Wegovy, or compounded semaglutide) or GIP/GLP-1 receptor agonist (Mounjaro, Zepbound or compounded tirzepatide) medication as part of your treatment plan for the management of weight or obesity. These medications work by mimicking the action of incretin hormones, which help regulate blood sugar levels, promote feeling full, and reduce food intake.Potential Benefits:- Weight loss or weight management- Improved blood glucose control- Reduced cardiovascular risk- Potential improvement in overall metabolic healthPotential Side Effects:Common side effects include nausea, vomiting, diarrhea, constipation, decreased appetite, indigestionSerious Side Effects:Pancreatitis, hypoglycemia, gallbladder disease, kidney problems, allergic reactions, gastroparesisRisks & Considerations:Pancreatitis: There is a risk of developing pancreatitis. If you experience severe abdominal pain, nausea or vomiting, you should contact your healthcare provider immediately.FDA Approved Brand Name Medications:Zepbound, Mounjaro, Ozempic, WegovyCompounded Medications:For patients who may benefit from a more specialized approach, we offer compounded formulations of semaglutide and tirzepatide. These compounded medications can be customized with alternative dosing schedules, alternative dosing frequencies, different routes of administration and/or additives intended to help reduce side effects commonly seen with the brand name products.Compounded medications are custom-prepared by licensed pharmacists to better meet an individual patient's specific needs. Unlike FDA-approved brand name products, compounded medications are not subject to the same rigorous testing and extensive clinical trials. This means that while they offer the advantage of customization, there may be differences in the consistency, efficacy and safety profiles compared to those of the branded products.By continuing with this treatment plan, you acknowledge that:- You have been informed of the available treatment options, including both FDA-approved brand name medications and compounded alternatives.- You understand that compounded medications are tailored to meet individual needs but are not subjected to the same level of testing as brand name products.- Your treatment plan will be determined based on your candidacy and specific health requirements, ensuring the most appropriate therapy for you.Please review this information carefully and reach out to our support team if you have any questions before proceeding.
    Press
    Enter
  • 49

    Thank you!

    This completes your initial pre-qualification questionnaire. Please click the SUBMIT button on this page to complete your submission, at which time your will be analyzed to see if you are qualified to be treated through our weight loss program.

    If approved, you will be redirected to a page where you will complete the checkout process to begin your treatment with us. Once payment has been completed on that screen, you will receive an email with the next steps to get started. 

    Thank you for trusting MinuteMD with your health, and we look forward to working with you!

    Press
    Enter
  • Should be Empty:
Question Label
1 of 49See AllGo Back
close